UXS1 inhibitors such as Tricostatin A and 5-Azacytidine alter the chromatin structure and DNA methylation states, thereby influencing gene expression profiles, including potentially the genes encoding UXS1. Compounds such as MG132 and Bortezomib disrupt proteasomal degradation, which can lead to the accumulation of proteins that negatively regulate UXS1. Inhibitors of key signaling pathways, such as LY294002, Wortmannin, PD98059, and SB203580, affect PI3K/Akt and MAPK signaling cascades, which are integral to the regulation of gene expression and protein activity, impacting the function of UXS1.
Rapamycin target the mTOR pathway, which could influence the synthesis and accumulation of UXS1. SP600125 and NF449 modulate JNK signaling and G-protein signaling pathways, respectively, which are implicated in a host of cellular processes that can extend to the regulation of UXS1. The Src family tyrosine kinase inhibitor PP2 can impact tyrosine phosphorylation-dependent signaling pathways, potentially affecting those that control the activity of UXS1.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Inhibits histone deacetylase (HDAC), leading to increased acetylation of histones, which can affect gene expression patterns including those of UXS1. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A cytidine analog that gets incorporated into DNA and RNA; it inhibits DNA methyltransferases, potentially altering the expression of UXS1. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that prevents the degradation of ubiquitinated proteins, potentially stabilizing negative regulators of UXS1. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that blocks the PI3K/Akt signaling pathway, which can regulate the expression or activity of UXS1. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A selective inhibitor of p38 MAP kinase, which is involved in cell differentiation and apoptosis, processes that can govern UXS1 activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An inhibitor of MEK1/2, which are upstream of ERK in the MAPK pathway; by inhibiting this pathway, it can modulate the function of UXS1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can affect protein synthesis and cell growth, potentially influencing the expression of UXS1. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor that can block downstream signaling affecting the activity or expression of UXS1. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK signaling, which can regulate various cellular processes including those associated with UXS1. | ||||||
NF449 | 627034-85-9 | sc-478179 sc-478179A sc-478179B | 10 mg 25 mg 100 mg | $203.00 $469.00 $1509.00 | 1 | |
A selective Gsα subunit inhibitor which can disrupt G-protein mediated signaling that may regulate UXS1. | ||||||